Bulletin of Experimental Biology and Medicine

, Volume 122, Issue 2, pp 862–864 | Cite as

Effect of ozone on the liver in experimental chronic hepatitis

  • K. N. Kontorshchikova
  • I. M. Solopaeva
  • S. P. Peretyagin
Experimental Methods for Clinical Practice

Abstract

Short-term administration of ozonized physiological solution to rats with chronic toxic hepatitis reduces the content of total lipids in the liver tissue, activates antioxidant enzymes, normalizes the level of diene conjugates, and reliably increases adenosine nucleotides, the number of normal hepatocytes being increased 2.2-fold. The data suggest that ozone can be used as a stimulator of regeneration of the pathologically altered liver.

Key Words

experimental chronic hepatitis ozone regeneration 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    G. N. Ivanova and L. N. Rubel',Zh. Evoluts. Biokhim.,5, 279–287 (1969).Google Scholar
  2. 2.
    K. N. Kontorshchikova,Lipid Peroxidation in Physico-Chemical Correction of Hypoxic Disturbances, Abstr. of PhD Thesis [in Russian], St. Petersburg (1992).Google Scholar
  3. 3.
    K. N. Kontorshchikova, I. M. Solopaeva, and S. P. Peretyagin,The Use of Ozonized Physiological Saline as a Regeneration Stimulator. Pat. 94-008835/14 (8908) of March 5, 1994.Google Scholar
  4. 4.
    E. I. Kuz'mina, L. S. Nelyubin, and M. K. Shchenikova, in:Biochemistry and Biophysics of Microorganisms [in Russian], Moscow (1986), pp. 41–48.Google Scholar
  5. 5.
    S. P. Peretyagin,Pathophysiological Bases of Ozone therapy in Posthemorrhagic Period, Abstract of PhD Thesis [in Russian], Kazan (1991), p. 37.Google Scholar
  6. 6.
    S. P. Peretyagin and K. N. Kontorshchikova,A Method of Activation of the Antioxidant Systems of the Organism, Pat. 4927153/14 of April 11, 1991.Google Scholar
  7. 7.
    I. M. Salopaeva and B. P. Salopaev,Stimulation of Regeneration of Pathologically Changed Liver and Chorionic Gonadotropin [in Russian], Nizhny Novgorod (1991).Google Scholar
  8. 8.
    H. Aebi, in:Methoden der Enzimatischen Analyses, H. U. Bergmayer (Ed.), Vol. 2, Berlin (1970), pp. 636–647.Google Scholar
  9. 9.
    D. L. Fletcher, C. J. Dillared, A. Y. Tappel,Anal. Biochem.,52, 497–499 (1973).CrossRefGoogle Scholar
  10. 10.
    M. Nishikimi, A. Rao, and K. Xagi,Biochem. Biophys. Res. Commun.,146, No. 2, 849–854 (1972).CrossRefGoogle Scholar
  11. 11.
    J. B. Smith and C. M. Ingerman,J. Lab. Clin. Med.,83, No. 1, 167–172 (1975).Google Scholar
  12. 12.
    F. S. Shenstone, in:Ultraviolet and Visible Spectroscopy of Lipids, New York (1971), pp. 77–91.Google Scholar
  13. 13.
    H. U. Wolf, in:Das Medizinische Ozone, Berlin (1977), p. 583.Google Scholar

Copyright information

© Plenum Publishing Corporation 1997

Authors and Affiliations

  • K. N. Kontorshchikova
    • 1
  • I. M. Solopaeva
    • 1
  • S. P. Peretyagin
    • 1
  1. 1.Central Research LaboratoryMedical AcademyNizhny Novgorod

Personalised recommendations